Validation of Tie2 as the First Tumour Vascular Response Biomarker for VEGF Inhibitors: VALTIVE1

NCT04523116 · clinicaltrials.gov ↗
UNKNOWN
Status
176
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Manchester

Collaborators